Skip to content

Clinical trials

Phase 3 Urinary Bladder, Overactive trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Phase: Phase 3 Country / region: Poland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20083
20092
20101
20123
20133
20141
20161
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan5
Astellas Pharma Europe B.V.4
Astellas Pharma Inc3
Pfizer3
Urovant Sciences GmbH3
Astellas Pharma Europe Ltd.2
Ipsen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive21
Urinary Incontinence9
Urinary Incontinence, Urge3
Urologic Diseases3
Nocturia2
Prostatic Hyperplasia2
Urinary Bladder Diseases2
Lower Urinary Tract Symptoms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.